Development of resistance to disoxaril in Coxsackie B1 virus-infected newborn mice

Antiviral Research

Volumn 60, Issue 1, 2003, Pages 35-40

  Nikolova, Ivanka ^a   Galabov, Angel S ^a  

^a INSTITUTE OF MICROBIOLOGY   (Bulgaria)

Author keywords

Coxsackie B1 virus; Disoxaril; Mice; Phenotype; Resistance

Indexed keywords

CAPSID PROTEIN; DISOXARIL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN; CONTROLLED STUDY; COXSACKIE VIRUS B; COXSACKIE VIRUS INFECTION; DRUG PROTEIN BINDING; IC 50; INOCULATION; MOUSE; NEWBORN; NONHUMAN; PATHOGENICITY; PHENOTYPE; PRIORITY JOURNAL; PROGENY; THERMOSTABILITY; VIRUS CAPSID; VIRUS INFECTIVITY; VIRUS PLAQUE; VIRUS RESISTANCE; VIRUS TITRATION;

ENTEROVIRUS;

EID: 0141456054     PISSN: 01663542     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0166-3542(03)00150-5     Document Type: Article

References (21)

1. Andries K., Dewindt B., Snoeks J., Wouters L., Moereels H., Lewi P.J., Janssen P.A.J. Two groups of rhinoviruses revealed by a panel of antiviral compounds present sequence divergence and differential pathogenicity. J. Virol. 64:1990;1117-1123.
2. Crotty S., Cameron C.E., Andino R. RNA virus error catastrophe: direct molecular test by using ribavirin. Proc. Natl. Acad. Sci. U.S.A. 98:2001;6895-6900.
3. Diana G.D., Pevear D.C., Otto M.J., McKinlay M.A., Rossmann M.G., Smith T., Badger J. Inhibitors of viral uncoating. Pharmacol. Ther. 42:1989;289-305.
4. Fogh J., Lund R. Cancer Res. 18:1958;692.
5. Groarke J.M., Pevear D.C. Attenuated virulence of pleconaril-resistant Coxsackievirus B3 variants. J. Infect. Dis. 179:1999;1538-1541.
6. Herrmann E.C. Jr., Herrmann J.A. A working hypothesis - virus resistance development as an indicator of specific antiviral activity. Ann. N.Y. Acad. Sci. 284:1977;632-637.
7. Loddo B. Development of drug resistance and dependence in viruses. Pharmacol. Ther. 10:1980;431-460.
8. Loddo B., Ferrari W., Spanedda A., Brotzu G. In vitro guanidino-resistance and guanidino-dependence of poliovirus. Experientia. 18:1962;518-519.
9. Melnick J.L., Crowther D., Barrera-Oro J. Rapid development of drug-resistant mutants. Science. 134:1961;557.
10. Moeremans M., De Raeymaeker M., Daneels G., De Brabander M., Aerts F., Janssen C., Andries K. Study of the parameters of binding of R 61837 to human rhinovirus 9 and immunobiochemical evidence of capsid-stabilizing activity of the compound. Antimicrob. Agents Chemother. 36:1992;417-424.
11. Nikolaeva L., Galabov A.S. Synergistic inhibitory effect of enviroxime and disoxaril on poliovirus type 1 replication. Acta Virol. 39:1995;235-241.
12. Nikolaeva L., Galabov A.S. In vitro inhibitory effects of dual combinations of picornavirus replication inhibitors. Acta Virol. 43:1999;303-311.
13. Nikolaeva L., Galabov A.S. Antiviral effect of the combination of enviroxime and disoxaril in coxsackievirus B1 infection. Acta Virol. 44:2000;73-78.
14. Pevear, D.C., 2001. The long and winding road to pleconaril. In: Program and Abstracts 14th International Conference on Antiviral Research, Seattle, WA, USA, 8-12 April 2001.
15. Pevear D.C., Tull T.M., Seipel M.E., Groarke J.M. Activity of pleconaril against enteroviruses. Antimicrob. Agents Chemother. 43:1999;2109-2115.
16. Pevear, D.C., Tull, T.M., Collett, M.S., Menegus, M.A., 2001. Sensitivity of clinical virus isolates from two pleconaril viral meningitis studies. In: Program and Abstracts, 14th International Conference on Antiviral Research, Seattle, WA, USA, 8-12 April 2001. Antiviral Res. 50 (132), A77.
17. Rombaut B., Andries K., Boeye A. A comparison of WIN 51711 and R78206 as stabilizers of poliovirus virions and procapsids. J. Gen. Virol. 72:1991;2153-2157.
18. Rossmann M.G. The structure of antiviral agents that inhibit uncoating when complexed with viral capsids. Antiviral Res. 11:1989;3-13.
19. Sierra S., Dávila M., Lowenstein P.R., Domingo E. Response of foot-and-mouth disease virus to increased mutagenesis: influence of viral load and fitness in loss of infectivity. J. Virol. 74:2000;8316-8323.
20. Smith T.J., Kremer M.J., Luo M., Vriend G., Arnold E., Kamer G., Rossmann M.G., McKinlay M.A., Diana G.D., Otto M.J. The site of attachment in human rhinovirus 14 for antiviral agents that inhibit uncoating. Science. 233:1986;1286-1293.
21. Voroschilova, M.K., 1979. Human Enterovirus Infections (in Russian). Meditsina, Moscow, pp. 148-189.